LEUCOMETHYLENE BLUE (is an active metabolite) | LEUCOMETHYLENE BLUE | ATC V03AB17 ATC V04CG05
TREATMENT OF METHEMOGLOBINEMIA AN OXIDATION-REDUCTION AGENT PROMOTES A NON-ENYZMATIC REDOX CONVERSION OF METHB TO HEMOGLOBIN CONVERTED INTO LEUCOMETHYLENE BLUE (LMB) BY NADPH REDUCTASE | - | | HEMOGLOBIN IRON | - more at DrugCentral | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |